Skip to main content
ASPHO Logo
Menu Journal My Account Contact Join/Renew
Login
  • Meetings & Events
    • Conference
      • 2023 Conference
        • 2023 Conference
        • Hotel and Travel
        • Health and Safety
        • Registration
        • Schedule
        • Commercial Support
          • Virtual Exhibitor and Engagement Opportunities
        • Back to Meetings
      • Meetings Archive
      • Press | 2018 Conference
      • 2018 Call for Papers and Posters
        • Back to Meetings
        • 2019 Conference
        • Schedule of Events
        • Registration Rates
        • Conference Planning Committee
        • Conference Hotel and Travel
        • Faculty
        • 2019 Call for Papers and Posters
        • Continuing Education
        • PBMTC
        • Accepted Papers and Posters
        • Corporate Symposia
        • MOC Opportunities
        • App - Thank you for Attending
        • 2019 Attendee List
      • 2019 Call for Workshops
      • 2018 Conference
        • Schedule of Events
        • Accepted Papers and Posters
      • 2016 Annual Meeting
        • Overview
        • Attendee List
        • ASPHO Virtual Bag
        • Corporate Forum Symposia/Education Theaters
        • Accepted Papers and Posters
          • Accepted A-G
          • Accepted H-M
          • Accepted N-Z
          • 2016 Searchable Abstract Database
        • Exhibit Hall
        • Sponsors
        • Annual Meeting Brochure
        • 2017 Call for Workshops
        • Virtual Bag
        • Schedule of Events
        • Continuing Education
        • Attendee List
        • 2017 Searchable Abstract Database
        • Accepted Papers and Posters
        • Corporate Forum Symposia/Education Theater
        • Travel
        • Program Committee
        • Commercial Support
        • Exhibit with ASPHO
    • Review Course
      • 2023 Review Course
        • Review Course 2023 Cancellation Policies and Disclosures
      • Anderson 2019
      • McClain 2019
      • Adams 2019
      • Moran 2019
      • Effinger 2019
      • Fangusaro 2021
      • Brown 2021
      • Young 2021
      • Harker-Murray 2021
      • Effinger 2021
      • Pai 2021
      • Grace 2021
      • Rogers 2021
      • Anderson 2021
      • Powers 2021
      • McClain 2021
      • Neunert 2021
      • Fleming 2021
      • Mullen 2021
      • Pommert 2021
      • Meade 2021
      • Greengard 2021
      • Fox 2021
      • Bercovitz 2021
      • Brock 2021
      • Adams 2021
      • Loh 2021
      • O'Brien 2021
      • Walterhouse 2021
      • Pulsipher 2021
      • Oberley 2021
      • Rodriguez-Galindo 2021
      • Kesselheim 2021
      • Frei-Jones 2021
      • Allen 2021
      • 2015 Online Review Course CME Certificates
      • 2019 Planning Committee
      • 2019 Schedule
      • 2019 Travel
      • 2019 Review Course Early Career
      • 2019 Review Course Directors
        • 2019 Review Course Faculty
      • Oberley 2019
      • O'Brien 2019
      • Pai 2019
      • Pulsipher 2019
      • Rodriguez-Galindo 2019
      • Rogers 2019
      • Walterhouse 2019
      • Young 2019
      • Park 2019
      • Malec 2019
      • Evaluations
      • Brown 2019
      • Allen 2019
      • Fangusaro 2019
      • Fleming 2019
      • Frei-Jones 2019
      • Grace 2019
      • Harker-Murray 2019
      • Heeney 2019
      • Kesselheim 2019
      • Loh 2019
      • Mascarenhas 2019
      • Neunert 2019
      • Fangusaro 2023
      • Adams 2023
      • Neunert 2023
      • Oberley 2023
      • Grace 2023
      • Effinger 2023
      • Nakano 2023
      • Brock 2023
      • Harker-Murray 2023
      • Meade 2023
      • Fleming 2023
      • Kesselheim
      • Kumar 2023
      • Anderson 2023
      • Malogolowkin 2023
      • Pommert 2023
      • Bercovitz 2023
      • Frei-Jones 2023
      • O'Brien 2023
      • Pai 2023
      • Young 2023
      • Fox 2023
      • Powers 2023
      • Pulsipher 2023
      • McClain 2023
      • Loh 2023
      • Greengard 2023
      • Frazier 2023
      • Brennan 2023
      • Walkovich 2023
      • Browning 2023
      • 2023 Faculty
        • Office Hours
        • Learning Objectives and CME
        • Faculty
        • Planning Committee
      • Mullen 2023
      • 2023 Schedule
      • 2023 Learning Objectives and CME
      • Review Course Archive
    • Events Calendar
  • Knowledge Center
    • Products
      • KARE Toolkit: Knowledge and Assessment Resources
        • CME for KARE
        • CME for RC On-Demand
        • CME for PHO Review Course On Demand
        • CME for KARE Plus
        • CME for KARE Plus Hematology
        • CME for KARE Plus Oncology
        • The KARE Toolkit - Index of Topics
      • Recordings
      • Webinars
      • ASPHOcast
      • 2020 Compensation Survey
    • Online Review Course
    • Pediatric Blood & Cancer
      • Access Journal
      • Online Access Instructions
    • ASPHO eNews
      • August 2015 Enews
      • June 2015 Enews
      • April 2015 Enews
      • February 2015 Enews
      • December 2014 Enews
      • October 2014 Enews
      • August 2014 Enews
      • June 2014 Enews
      • April 2014 Enews
      • February 2014 Enews
      • December 2013 Enews
      • October 2013 Enews
      • August 2013 Enews
      • June 2013 Enews
      • April 2013 Enews
      • February 2013 Enews
      • October 2014 Enews
      • October 2015 Enews
      • December 2015 Enews
      • February 2016 Enews
      • April 2016 Enews
      • June 2016 Enews
        • DSIG Student Registration
      • August 2016 Enews
      • October 2016 Enews
      • December 2016 Enews
      • February 2017 Enews
      • April 2017 Enews
      • June 2017 Enews
      • August 2017 Enews
      • October 2017 Enews
      • December 2017 Enews
      • February 2018 Enews
      • April 2018 Enews
      • June 2018 Enews
      • August 2018 eNews
      • October 2018 eNews
      • February 2019 eNews
      • Member Insights: eNews 2018 Highlights
      • April 2019 eNews
      • June 2019 eNews
      • August 2019 eNews
      • October 2019 eNews
      • December 2019 eNews
      • February 2020 eNews
      • April 2020 eNews
      • June 2020 eNews
      • August 2020 eNews
      • October 2020 eNews
      • December 2020 eNews
      • April 2021 eNews
      • June 2021 eNews
      • August 2021 eNews
        • August 2021 President's Message
      • December 2021 eNews
      • February 2022 eNews
      • April 2022 eNews
      • June 2022 eNews
      • August 2022 eNews
      • October 2022 eNews
      • December 2022 eNews
      • February 2023 eNews
    • Pediatric Blood & Cancer - Call for Applications for Deputy Editor
    • October 2015 Enews
    • Advocacy Sample
    • News Briefs
    • Health Policy & Advocacy
      • 2016 August Advocacy Brief
      • 2016 December Advocacy Brief
      • 2017 February Advocacy Brief
      • 2017 May Advocacy Brief
      • 2017 September Advocacy Brief
      • 2017 November Advocacy Brief
      • 2018 Advocacy Brief - March
      • Contact Your Members of Congress
      • 2018-Advocacy-Brief-June
      • 2018-Advocacy-Brief-September
      • Advocacy Brief December 2018
      • 2019 Advocacy Brief - March
      • March 2019 Advocacy Brief
      • June 2019 Advocacy Brief
      • September 2019 Advocacy Brief
      • March 2020 Advocacy Brief
      • June 2020 Advocacy Brief
      • September 2020 Advocacy Brief
      • December 2020 Advocacy Brief
      • June 2021 Advocacy Brief
      • September 2021 Advocacy Brief
      • March 2022 Advocacy Brief
      • June 2022 Advocacy Brief
      • September 2022 Advocacy Brief
    • 2017 Workforce Survey Report
    • Help Fund the STAT Act
    • Practice and Quality
      • Choosing Wisely®
      • Position Paper
      • Endorsements
      • ASPHO Endorsements member only
  • Career Development
    • Mentoring
      • Early Career Mentoring
    • Awards
      • Distinguished Career Award
      • Oski Memorial Lectureship
      • International Travel Awards
      • Arceci Innovation Award
      • Buchanan Lectureship
      • Young Investigator Award
      • Young Investigator Form
      • EC Travel Stipend Form
      • Early Career Travel Stipend
      • Advanced Practice Provider Award
      • Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
    • Career Center
    • Fellowship Resources
      • Post-PHO Fellowship Program Directory
      • Fellowship Program Directors' Resources
    • Certification
      • Continuing Medical Education
      • advocating for moc
      • ABP MOC Letter Nov 2015
      • ABP Hematology/Oncology Content Outline
    • 2019 ASPHO Award Recipients
    • Workforce
  • Membership
    • Who Belongs
    • Benefits
    • Join Us
    • Renew
    • Membership Application
    • Fellows Group Application
    • Member Community
    • Special Interest Groups
      • Adolescent and Young Adult SIG
      • Advanced Practice Provider SIG
      • Cancer Predisposition SIG
      • Clinical Immunology SIG
      • Diversity SIG
        • 2017 DSIG Travel Award
      • Global Hem Onc SIG
      • Hemoglobinopathy SIG
      • Hospitalist Medicine SIG
      • Informatics, Innovation and Entrepreneurship SIG
      • Integrative Pediatric Hematology/Oncology SIG
      • Palliative Care SIG
      • Physician Scientist SIG
      • Quality Improvement and Patient Safety SIG
      • Small Program SIG
      • Vascular Anomalies SIG
      • Clinical Immunology SIG Webinar
      • Well-Being SIG
    • Enriching the Future
      • ETF Donors
      • ETF FAQ
      • ETF Programs
      • ETF Award Recipients
      • Donate
    • Stay Connected with ASPHO
    • New Member
    • Trainee Membership Level
    • Strengthen Your Everyday Practice
  • About
    • Governance
      • 2017 Election Nominations
      • 2019 Board and Nominating Committee members
      • Board of Trustees
      • Leadership Development & Election Process
      • Nominating FAQs
      • Strategic Plan
        • Leadership Domain
        • Education Domain
        • Career Domain
        • Administration Domain
      • Volunteer Opportunities
        • Early Career Council
    • Policies
      • Advertising Sponsorship
      • Support of CME
      • Committee Policies, Responsibilities, and Resources
      • Conflict of Interest and Disclosure for Volunteers
      • Distinguished Career Award Eligibility Criteria
      • Diversity Statement
      • Investment
      • Member Mailing List
      • Oski Eligibility Criteria
      • Presidential Stipend
      • Records Retention
      • Reserve Fund
      • Reviews and Endorsements
      • Speaker Reimbursement
      • Surveying Members
      • Whistleblower
      • Workshop Session
      • Young Investigator Award
      • Early Career Travel Stipend
      • Buchanan Lectureship Eligibility
      • ASPHO Statements
    • Terms of Use
    • Contact Us
    • 2016 Election Nominations
    • 2015 Election Candidates
    • FDA Approves Dinutuximab
    • Q&A Amy Billett
    • Fund Raising Policy
    • Support and Advertising
      • Exhibit
      • Advertising
      • Industry Relations Council
      • Grants
    • Diversity & Inclusion
    • Donate
  • 2017 Annual Meeting Session Recordings
  • 2018 Annual Meeting Session Recordings
  • George R. Buchanan Lectureship Award Presentation
  • Cancer Predispositions in Clinical Practice
  • Evidence and Equipoise in Pediatric Thrombosis - Updates from Randomized Controlled Trials
  • Playing on Our Strengths - Developing Interprofessional Teams in Pediatric Hematology-Oncology
  • Providing Optimal Pediatric Palliative Care: Overcoming the Barriers
  • When in Quebec, Do What the Quebecers Do (Part Deux) - It's All About Platelets!
  • Allogeneic Hematopoietic Stem Cell Transplantation (SCT) for Pediatric Patients with ALL in the era of Tyrosine Kinase Inhibitors, Novel Immunotherapies and 'MRD Status'
  • Award Presentations
  • Hemophilic Arthropathy, More Than Meets the Eye: Advances in Early Disease Detection from Clinical Tools to Musculoskeletal Imaging
  • ZFNs, CrispR/Cas9 and TALENS- Oh My!
  • Collaboration in the Treatment of Liver Tumors
  • Leukemia
  • Solid Tumors/Lymphoma
  • Hematology I
  • Beyond Antibodies and CAR T Cells: Challenges and Opportunities in Manipulating the Pediatric Cancer Immunome
  • Blood Clots in Sick Kids: A critical mini-review of venous thrombo-embolism in selected high-risk pediatric populations
  • It's not just about Diversity: Improving the Outcomes for All by Moving toward Equity
  • Children's Oncology Group (COG)
  • Outcomes Research
  • Social Media: The Good, The Bad, and Beyond
  • Sickle Cell Disease in the AYA population: Management Challenges for the Pediatric Hematologist
  • Molecularly Defined Rare Pediatric Sarcomas: An Update for the General Oncologist
  • Mechanisms of Tumor Microenvironment Immune Mediated Resistance and Methods of Therapeutic Circumvention
  • Behind the Scenes at Pediatric Blood & Cancer: Everything You Always Wanted to Know About Getting Published
  • New Insights in Inherited Hematologic Diseases
  • Changing Workforce of Pediatric Hematology/Oncology
  • New Diagnostic and Therapeutic Approaches of Opportunistic (Viral/Fungal) Infections in the Pediatric Cancer Patient
  • New Mutations and Targeted Therapies in Langerhans Cell Histiocytosis
  • Physician, Sustain Thyself: Building Resilience to Prevent Burnout
  • Practicing Precision in Pediatric Oncology: Three Perspectives
  • What's Happening in DC? A Look at ASPHO Advocacy Efforts
  • Critical Care of the Immunocompromised Pediatric Hematology/Oncology Patient
  • Brain Tumors
  • Hematology II
  • Sponsor, Exhibit, and Advertise
    • Exhibits
    • Advertising
    • Industry Relations Council
    • Exhibits Adveritising
  • Ward Testing OSE
  • 2018 Session | George R. Buchanan Lectureship Award Presentation
  • 2018 Session | Plenary Paper Session 2001-2002
  • 2018 Session | St. Baldrick's Foundation Robert J. Arceci Innovation Award Announcement
  • 2018 Session | Plenary Session—Health Care in the Current Political Climate: Stormy Days Ahead?
  • 2018 Session | Pediatric Ependymoma: The Science Driving Patient Care
  • 2018 Session | Iron: Let's Get Pumped
  • 2018 Session | Extracellular Vesicle Trafficking—Biology and Translational Impact in Hematology and Cancer
  • 2018 Session | Relapsed, Refractory, Metastatic Bone Sarcomas: New Insights on Pathogenesis, Prognosis and Treatment
  • 2018 Session | Alpha Thalassemia—A Growing Public Health Disease with Changing Landscape of In-Utero and Post-Natal Therapy
  • 2018 Session | Decision Making in Benign Hematology: Living in a World Without Randomized Trials
  • 2018 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
  • 2018 Session | Early Career Travel Stipend Awards
  • 2018 Session | Young Investigator Award Presentations
  • 2018 Session | Management of Extracranial Germ Cell Tumors in Adolescent and Young Adult Population
  • 2018 Session | Challenging Hematologic Complications Post–Stem Cell Transplantation and Beyond
  • 2018 Session | Advanced Symptom Management and End-of-Life Care: Multidisciplinary Primary Palliative Care for Pediatric Hematologists/Oncologists
  • 2018 Session | Paper Session - Solid Tumor
  • 2018 Session | Paper Session - Hematology
  • 2018 Session | Vascular Anomalies: The Great Mimickers
  • 2018 Session | Addressing Sexual Health in Adolescent and Young Adult Patients: What You Should Know as a Pediatric Hematology/Oncology Care Provider
  • 2018 Session | Navigating Intravascular Bottlenecks: A Critical Mini-Review of Pediatric Venous Thromboembolism in the Setting of an Anatomical Thrombophilia
  • 2018 Session | Paper Session - Children's Oncology Group (COG)
  • 2018 Session | Paper Session - Hematology Science
  • 2018 Session | Can Late Effects be Prevented in Pediatric Oncology?
  • 2018 Session | Clash of the Titans: Debates on Best Management of Patients with Bleeding Disorders
  • 2018 Session | Providing Effective Feedback: The Currency of Conflict Resolution
  • 2018 Session | Recent Advances and New Approaches to Rare Hematological Malignancies
  • 2018 Session | Primary and Secondary Stroke Prevention in Sickle Cell Disease: The Debate
  • 2018 Session | Combating an Unmet Need: Psychosocial Health
  • 2018 Session | Renal Tumors Beyond Wilms
  • 2018 Session | Pediatric and Neonatal Transfusion Medicine
  • 2018 Session | Mobile Applications in Clinical Practice
  • 2018 Session | Presidential Symposium—Partnering with Patients and Families to Improve Research and Clinical Decision-making
  • 2018 Session | Review of Rare Pediatric Head and Neck Tumors for the General Oncologist
  • 2018 Session | Emerging Therapies in Hemophilia
  • 2018 Session | How Should You Treat That Bug? A Debate About Antimicrobial Management in Fever and Neutropenia
  • 2018 Session | Paper Session with Luminary Investigator - Leukemia
  • 2018 Session | Paper Session with Luminary Investigator - Hematology
  • 2018 Session | Frank A. Oski Memorial Lectureship Award Presentation
  • December 2018 eNews
  • 2019 Session | Splenectomy - The Great Debate
  • 2019 Session | DICER1: Updates on Biology and Clinical Management
  • 2019 Session | Burnout in Pediatric Hematology/Oncology: Moving from Discussion to Action
  • 2019 Session | Diagnostic and Management Conundrums Surrounding Women with Heavy Menstrual Bleeding and Underlying Bleeding Disorders
  • 2019 Session | All That Glitters is Not Gold – How We Differentiate Primary HLH from Fake News
  • Models for International Pediatric Oncology Outreach
  • 2019 Session | Navigating Genetic Testing in the Pediatric Hematology Setting
  • 2019 Session | Radiation Therapy for Pediatric Cancer Patients: Updates and New Modalities
  • 2019 Session | The Microbiome: What Is It and Why Do We Care?
  • 2019 Session | Brain Attack: Therapeutic Advances in Neonatal and Childhood Stroke
  • 2019 Session | Advances in Pediatric AML
  • 2019 Session | Improving Medication Adherence for Adolescents and Young Adults: Is Technology the Answer?
  • 2019 Session | Metabolism in Pediatric Hematology/Oncology - Presidential Symposium
  • 2019 Session | Too Much of a Good Thing – Myeloproliferation in Children
  • 2019 Session | Multiple Bony Lytic Lesions, but Not Langerhans Cell Histiocytosis (LCH) – Now What?
  • 2019 Session | Savior Siblings: Medical, Ethical, and Psychosocial Considerations in using Preimplantation Genetic Diagnosis (PGD) to Ensure a Matched Sibling Donor for Hematopoietic Stem Cell Transplantation (HSCT)
  • 2019 Session | George R. Buchanan Lectureship Award Presentation
  • 2019 Session | 2019 St. Baldrick’s Foundation Robert J. Arceci Innovation Award Announcement and Past Recipient Presentation
  • 2019 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship Announcement and Frank A. Oski Memorial Lectureship Award Presentation
  • 2019 Session | New Paradigms for Severe Aplastic Anemia: Genetic Screening, Eltrombopag, and Up Front Unrelated Donor BMT
  • 2019 Session | Not Too Young for That Cancer: Adolescent and Young Adult Carcinomas
  • 2019 Session | Transforming the Treatment of Chronic Pain
  • 2019 Session | Putting an End to End Organ Damage in Sickle Cell Disease
  • 2019 Session | Defining Pediatric MDS: A Morphologic or Molecular Diagnosis?
  • 2019 Session | The Power of One: Present Challenges in Treating Rare Diseases
  • 2019 Session | Hematological Manifestations of Immune Deficiencies and Dysregulatory Disorders: When should you look harder for underlying causes of Autoimmune Cytopenias?
  • 2019 Session | Oncofertility Programs: More Than Just Sperm Banking
  • 2019 Session | The (Financial) Cost of a "Cure"
  • 2019 Session | (2001) Potential Utility of MRD to Identify Relapse in pALL Patients Treated with Tisagenlecleucel
  • 2019 Session | (2002) Lentiglobin Gene Therapy in Transfusion-Dependent Β-Thalassemia Patients with Non-β0/β0 Genotypes
  • 2019 Session | (2003) Mechanisms of Resistance to the Type II JAK2 Inhibitor CHZ868 in B-Cell Acute Lymphoblastic Leukemia
  • 2019 Session | (2004) Discovering Noncoding Genetic Elements that Regulate Globin Synthesis
  • 2019 Session | (2005) Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis: Safety & Efficacy
  • 2019 Session | (2006) Modeling IKZF1 Lesions in B-cell Acute Lymphoblastic Leukemia Reveals Potential Therapeutic Targets
  • 2019 Session | (2007) Prognostic Determinants in Childhood T-cell Acute Lymphoblastic leukemia: Results of DFCI 05001
  • 2019 Session | (2008) Gap Junction Interference increases Apoptosis in ALL cells and augments effects of Antimetabolites
  • 2019 Session | (2009) Hydroxyurea Lowers Tricuspid Regurgitant Jet Velocity in Children with Sickle Cell Anemia
  • 2019 Session | (2010) Novel Next-Generation Sequence based Assay for Non-Invasive Prenatal Testing of Sickle Cell Disease
  • 2019 Session | (2011) Gabapentin for Pain in Sickle Cell Disease: Results of a Randomized Phase II Clinical Trial
  • 2019 Session | (2012) Quality of Life is the most important Indication for Second-Line ITP Treatment in Children
  • 2019 Session | (2013) BCL2-Inhibitor Response in Neuroblastoma: Biomarkers and Therapy Resistance
  • 2019 Session | (2014) The Clinical Application of Molecular Testing in Pediatric Solid Tumors: An Institutional Experience
  • 2019 Session | (2015) Enhancing Tumor Directed T Cells with an Interleukin-7 Signal Modulator
  • 2019 Session | (2016) Epigenome Screening Identifies Transcriptional Elongation as Therapeutic Vulnerability in DIPG
  • 2019 Session | (2017) Levofloxacin Prophylaxis
  • 2019 Session | (2018) Renal Tumors: Future Roadmap
  • 2019 Session | (2019) Soft Tissue Sarcoma
  • 2019 Session | (2020) Realizing Effectiveness across Continents with Hydroxyurea (REACH): A Prospective Multi-National Trial of Hydroxyurea for Sickle Cell Anemia in Sub-Saharan Africa
  • 2019 Session | (2021) Leucine for the Treatment of Transfusion Dependence in Patients with Diamond Blackfan Anemia
  • 2019 Session | (2022) A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds
  • 2019 Session | (2023) Peripherally Inserted Central Catheters (PICCs), the Leading Cause of Central Venous Catheter Associated Thrombosis in Children
  • 2019 Session | The Role of Survivorship Research in Advancing Childhood Cancer Care and Quality of Survival
  • 2019 Session | (2024) Septic Shock (SS) Incidence in National ALL & AML Cohorts using Administrative & Clinical Trial Data
  • 2019 Session | (2025) Nelarabine Abrogates Relapse Rates in CNS-3 T-ALL: A Report from Children’s Oncology Group AALL0434
  • 2019 Session | (2026) Current Cancer Survivorship Practices: A Report from the Children’s Oncology Group (COG)
  • 2019 Session | (2027) Intra-Arterial Chemotherapy for Retinoblastoma: A 7-year Single Institution Experience
  • 2019 Session | Advancing Discovery in Hematology: Bench to Bedside? No. Bedside to Bench to Bedside...
  • 2019 Session | (2028) The Shwachman Diamond Syndrome Registry: Hematologic Complications
  • 2019 Session | (2029) Characteristics and Outcomes of Unprovoked Venous Thromboembolism in the Pediatric Population
  • 2019 Session | (2030) Third Party VST are an effective Therapy for the Treatment of BK-Virus Reactivation after Transplant
  • 2019 Session | (2031) Inhibition of Nemo-Like Kinase improves Erythropoiesis in Models of Diamond Blackfan Anemia
  • 2019 Annual Meeting Session Recordings
  • CI SIG Webinar
  • October 2021 eNews

eNews

February 2023

Table of Contents

  • President's Message
  • Upcoming Programming
    • Program Director Town Hall
    • ASPHO Webinar Series
    • KARE: Knowledge and Assessment REsources
  • Society News
    • Joint Policy Review Groups
    • Pediatric Blood & Cancer Update
    • Career Path Spotlight
  • Membership Bulletin
    • Welcome, New Board Trustees
    • Benefits of Mentoring
    • Committee Currents: Member Engagement & Review Course
    • SIG Spotlight: Vascular Anomalies and Quality Improvement and Patient Safety SIGs
    • New Product for Fellows PLUS Members
    • Welcome, New Members
  • Case Quiz
  • Conference Central
    • Registration is Open
  • Career Center

President's Message

Douglas K. Graham MD PhD

Enhance Your Professional Development with ASPHO

Doug Graham, MD PhD

ASPHO’s Community/Professional Development strategic goal states ASPHO will “deliver opportunities for career development and community engagement.” ASPHO aspires to play an important role in mentoring and career development for pediatric hematologists and oncologists at every point in their career: early, mid, and late.

ASPHO has a strong history of providing mentoring, networking, and career development for early career members, including trainees and junior faculty. Additionally, as part of ASPHO’s overall workforce strategy, a new membership category was created for medical students and residents to encourage those interested in entering our field as clinicians, researchers, and educators. Our hematology/oncology trainees and junior faculty have provided very positive feedback regarding opportunities tailor-made for them at the ASPHO Conference:

  • Speed Mentoring and Early Career Roundtable events provide a forum for mentees and mentors to learn, develop their skills, and support others in career development.
  • Workshops and Symposia have historically provided valuable information related to choosing a mentor, contract negotiations, tips for writing grants, and how to achieve work-life balance.

In addition to these offerings at the ASPHO Conference, the Early Career Mentoring Program had a record number of virtual matches in 2022. Since its inception, ASPHO has matched 130 mentees with mentors to help guide them. Recent mentees share their experiences in this new video (aspho.org/mentoring).

The recently approved ASPHO Strategic Plan confirmed our commitment to also provide career development opportunities for our mid- and late-career members. Annual meetings and webinars throughout the year will feature topics that specifically benefit these member groups. Further, ASPHO has prioritized mentoring experiences for our mid-career members, including a Mid-Career Mentoring Program developed by the Professional Development Committee that has met with very early success. This program is a year-long endeavor that commences with an in-person meeting at the ASPHO Conference. A former mentor shared her experience: “I was a bit surprised on how VERY positive the experience was for me as the mentor. Being truly external—this was a remarkable relationship in which I could be certain that I was giving my best and most selfless mentoring and advice and learning myself about being a better mentor.”

Our members at all career stages can benefit from volunteering to serve on one of our ASPHO committees. ASPHO seeks to recruit committee volunteers who reflect the diversity of its membership, and this includes creating committee membership with faculty at different career stages. I have personally been involved in ASPHO committees for more than 20 years, starting as a member of the Training Committee as a hematology/oncology fellow followed by membership on the Conference Planning Committee, Young Investigator Committee (now part of the Professional Development Committee), Nominating Committee (now Leadership Development Committee), Finance Committee, and Board of Trustees. I found committee service to be an effective way to build leadership skills and provide career development as well as network with colleagues across the country. In total, ASPHO offers opportunities to participate in nine committees and 16 special interest groups.

Our 2023 conference is scheduled for May 10–13 in Fort Worth, TX. The meeting will provide high-quality education and chances to receive formal mentoring and career development as well as informal time to network with mentors and colleagues. I look forward to seeing you in Fort Worth!

Upcoming Programming

Read about upcoming programs, webinars, and products to support your work.

Program Director Town Hall

The ASPHO Training Committee will host a town hall for fellowship program directors on Wednesday, February 22, 4–5 pm CT. We will be joined by Dr. David Turner, vice president for Competency-Based Medical Education for the American Board of Pediatrics, as he discusses Entrustable Professional Activities (EPAs), including future strategies for utilizing these in fellow evaluations.

Register for the town hall

Register for Remaining 2022–2023 ASPHO Webinars

Gain new perspectives on issues relevant to clinicians, administrators, and investigators by attending upcoming live ASPHO Webinars featuring Q&A with presenters. Registration includes attendance at the live program and on-demand access.

  • The Use of Yoga for Children with Cancer & Blood Disorders, Tuesday, February 28, 3 pm CT
  • Vignettes of Vanquishing Vexing Variants, Tuesday, March 7, 3 pm CT
  • Hope and Realism: Partnering with Patients and Families Who Hope for Cure Despite Poor Prognoses, Wednesday, April 26, 3 pm CT

Did you miss a recent webinar? Register for past webinars and watch the full presentation and Q&A conversation on demand. Visit aspho.org/webinars for details on the 2022-2023 Webinar Series.

New KARE Toolkit Coming Soon

The 2023 edition of ASPHO’s KARE Toolkit—Knowledge and Assessment REsources will be available in February, with updated information to keep you current on essential aspects of pediatric hematology/oncology (PHO). Look for details on how clinicians in every role, as well as researchers, can benefit from the content.

Society News

AAP-SOHO/ASPHO Joint Policy Review Group

The American Academy of Pediatrics–Section on Pediatric Hematology/Oncology (AAP-SOHO) and ASPHO continue to collaborate via a joint policy review group to provide pediatric hematology/oncology review expertise regarding policy and other related documents for providers who care for children with blood disorders and cancer.

This collaborative group was established in 2014, and since its inception, our policy review groups have reviewed more than 250 policy statements, clinical practice guidelines, book chapters, and other documents from AAP and other societies. Currently, 11 review groups, which engage nearly 60 members of our organizations, help to cover this review process:

  • Solid tumors
  • Nonmalignant hematology
  • Leukemia/lymphomas/lymphoproliferative disorders
  • Healthcare delivery and health policy
  • Coagulation disorders
  • Hemoglobinopathies
  • Stem cell transplantation
  • Oncology supportive care
  • Neuro-oncology
  • Transfusion
  • Survivorship and late effects group

The review group terms are 3 years and renewable, and the end of 2022 marked the conclusion of the most recent 3-year term. All review group members were evaluated for eligibility for reappointment in late fall of 2022, and a call for volunteers was held to fill any gaps identified for particular review groups. Thank you to those who submitted their interest in joining the review group. The updated review groups are now set and began a new 3-year cycle in January 2023. We are very appreciative of the joint review group members who continue to volunteer their time and expertise to support this valuable collaboration.

ASPHO would also like to take this time to express our sincere appreciation and congratulations to our colleague Suzanne Kirkwood from AAP-SOHO as she retires after 14 years at AAP. Suzanne served as a manager for SOHO, which included leading this collaborative AAP-SOHO/ASPHO Joint Policy Review Group, and she has been a great ally for ASPHO and the PHO subspecialty.

PBC Journal Affiliation

ASPHO and the International Society of Paediatric Oncology (SIOP) signed a new affiliation agreement with Wiley Publications, which owns and publishes Pediatric Blood & Cancer (PBC), for cosponsorship of the journal for 5 years (from January 2023 to December 2027). Members of ASPHO and SIOP receive an annual online subscription as part of their membership.

PBC’s aim and scope is to publish the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood, including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. PBC will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.

Both organizations are grateful for the continued leadership of Dr. Peter Newburger and Dr. Thomas Gross, PBC editor-in-chief and deputy editor, respectively.

Career Path Spotlight

The ASPHO Training Committee is pleased to present this month’s edition of the Career Path Spotlight Series. This resource showcases the career paths of a variety of ASPHO physician members and informs medical students, residents, PHO fellows, and early-career junior faculty members of the career opportunities available to them.

This month’s spotlight features Dr. Joanna Yi from Texas Children’s Hospital/Baylor College of Medicine in Houston.

Joanna Yi

Access the February Spotlight

Membership Bulletin

Announcing the 2023–2024 ASPHO Board of Trustees

After careful deliberations, the ASPHO Leadership Development Committee is pleased to announce the following slate of candidates for the officer and at-large positions on the ASPHO Board of Trustees.

In accordance with the ASPHO Bylaws, recently approved by the membership in 2022, this slate was presented to the current ASPHO Board of Trustees and approved.

Vice President: Jeffrey Hord, MD, Akron Children’s Hospital

Secretary-Treasurer: Daniel Wechsler, MD PhD, Children’s Healthcare of Atlanta/Emory University

At-Large Trustee: Amir Mian, MD MBA, Georgia Cancer Center/Children’s Hospital of Georgia

At-Large Trustee: Rich Tower, MD, Medical College of Wisconsin

The new Trustees join Caroline Hastings, MD (President), Douglas Graham, MD PhD (Past President), Sarah Alexander, MD (Trustee), Michelle Hudspeth, MD (Trustee), Michael Jeng, MD (Trustee), and Maria Velez, MD (Trustee), who will continue their leadership on the board.

Changes in the Bylaws, being implemented for the first time in our elections process, are to support and encourage a diverse and inclusive leadership environment, including adopting 1-year terms for President, Vice President, and Past President and creating a rigorous board elections process with a noncompetitive slate to better support diversity of the membership in every way: specialty, professional setting, leadership competencies, demographics, and other characteristics in accordance with the Society’s Diversity Statement. To learn more about ASPHO’s leadership development efforts, visit our website.

ASPHO’s Mid-Career Mentoring Program Announces 2023–2024 Mentees

The Professional Development Committee fielded a successful call for mentee applicants for our 2023–2024 Mid-Career Mentoring Program. To be eligible for consideration, applicants needed to have completed primary PHO fellowship between 2007 and 2014. After careful vetting of the applications, and with consideration for multiple points of diversity, seven applicants were selected to participate in this year’s program.

Congratulations to those members selected to participate!

  • Jesús Ardila, MD, Fundación POHEMA/Clínica Imbanaco, Cali, Colombia
  • Nitya Bakshi, MD MS, Children’s Healthcare of Atlanta/Emory University
  • Amanda Blair, MD, Brenner Children’s Hospital/Wake Forest Baptist Medical Center
  • Dorothea Douglas-Lindsay, MD, Nemours Children’s Hospital–Orlando
  • Erika Friehling, MD MS, UPMC Children’s Hospital of Pittsburgh
  • Hemalatha Rangarajan, MD, Nationwide Children’s Hospital
  • Mindy Simpson, MD, Rush University Medical Center
  • Stacie Stapleton, MD, Johns Hopkins All Children’s Hospital

Mentors are currently being finalized for these individuals. The 2023–2024 program will kick off with a group meeting at the 2023 ASPHO Conference in Fort Worth.

Want to learn more about ASPHO’s Mid-Career Mentoring Program? Visit the ASPHO Mentoring webpage.

Committee Currents

A Shout-Out from the Member Engagement Committee

Merriam-Webster Dictionary, America’s most trusted online dictionary, defines the verb to engage as “to offer, to attract and hold, to bring together, to provide occupation for, or to induce to participate,” among the many meanings related to how engagement can happen. One may ask how ASPHO could put these concepts into practice.

Perhaps the answer lies in the original vision that ASPHO’s founders had and the main goals that continue to guide the Society in its pursuit for excellence: impact/advocacy; discovery/research; education/knowledge, community/professional development; and practice/workforce. The Member Engagement Committee, tasked with promoting member knowledge and professional development, does so by identifying and evaluating engagement opportunities, including communities of practice (SIGs) and engagement-related member benefits and modes of communication/collaboration.

Do you aspire to keep up-to-date clinically, learning directly from national leaders in this field? Or to screen for the latest job opportunities available in the market? Have you ever wanted to play a role in advocacy or in diversity, equity, and inclusion? How about being introduced to leadership skills or being able to identify a junior/mid-level career mentor who will help you reach a career breakthrough? And what about presenting your research and evaluating where your academic work stands in comparison to your peers? In brief, these are among the many possibilities currently available with ASPHO, by participating in mentoring and other Society programs, networking on the member community, and volunteering with a committee or special interest group.

Since its creation in 1981, physicians specialized in pediatric hematology/oncology have made ASPHO their professional societal home, a place where they have felt represented and heard. Hosting almost 2,000 individuals from their career inception to late-career stages, ASPHO is an organization big enough to claim national representation within one of the biggest pediatric subspecialties—pediatric hematology/oncology—but yet a group where each member can still be heard.

Over the years, ASPHO has strived to incorporate the fast-growing body of knowledge in this field into its educational program. Similarly, it has served as a platform for active membership representation, offering professional growth opportunities required by individuals pursuing clinical and academic careers and inviting ASPHO members to participate and to influence the Society’s growth and reshape it to a contemporary society that can address the unmet needs of its time.

The Member Engagement Committee encourages you to participate, take advantage of your membership benefits and exclusive opportunities, and invites your suggestions for enhancing ASPHO engagement at This email address is being protected from spambots. You need JavaScript enabled to view it. .

Review Course Committee

The 2023 ASPHO Pediatric Hematology/Oncology Review Course concluded its live portion January 26-29 with 19 sessions presented during the 4-day course. An additional 14 sessions are available on-demand, and course registrants receive on-demand access to all 33 sessions. Over 350 attendees joined the course, many preparing for the upcoming American Board of Pediatrics subspecialty exam, while others joined for a thorough review of key concepts in the field. Special thanks to outgoing Review Course Committee Chair, Dr. Paul Harker-Murray, and Vice Chair, Dr. Cindy Neunert, and the entire committee for coordinating an excellent event. If you missed it and want access to the educational content, please watch for information on purchasing the Review Course On-Demand and KARE resources later this month.


SIG Spotlight

Members are the engine of ASPHO’s 16 Special Interest Groups, in which common interests and challenges drive discussion to spur solutions, learning, and collaboration. In this issue of eNews, read about activities and issues being addressed by the Adolescent and Young Adult (AYA) and Palliative Care SIGs.

Vascular Anomalies Special Interest Group

The field of pediatric vascular anomalies has seen tremendous advancement in the last decade, and one great driver has been the ASPHO Vascular Anomalies Special Interest Group (VA SIG). ASPHO provided our field its first home in 2012, and more than 250 members provide a foundation for rapid growth. Early development of a VA SIG Practice Group led to standardizing approaches to classification, diagnosis, and treatment. These recommendations have gone on to fill textbook chapters and journal articles as the first practice guidelines for our field. The VA SIG Education Group maintains the “VA 101” education curriculum for providers and organizes triennial half-day primer sessions for the broader ASPHO community. Members of the VA SIG Research Group became the first to conduct clinical research in vascular anomalies across North America and have since completed retrospective clinical and survey studies.

More than a decade of accomplishments is due to the dedication of VA SIG members and to leadership whose individual participation has made a collective impact in the field. Our annual SIG meeting at the ASPHO Conference is complemented by a fall VA SIG in-person working meeting hosted by one of our member institutions. Each SIG working group also carries out regular virtual meetings to maintain productivity. One recent achievement includes publication of a dedicated volume of Pediatric Blood & Cancer that included a series of vascular anomalies manuscripts all started within the ASPHO VA SIG.

We thank ASPHO for continuing to provide the field of pediatric vascular anomalies with a medical home in the ASPHO VA SIG, and we welcome all who share an interest to join and help move the field forward together!

Quality Improvement and Patient Safety Special Interest Group

Patient Safety Awareness Week is March 12–18, 2023!

Did you know?

  • Preventable hospital errors are the third leading cause of death in the United States.
  • Hospitalized pediatric inpatients are three times more likely than adults to experience adverse drug events.
  • Approximately 60% of the 70,000 adverse events occurring annually in hospitalized children are preventable.

Providing safe care to pediatric hematology and oncology patients is especially challenging due to its inherent complexity.

The Quality Improvement and Patient Safety Special Interest Group (QIPS SIG) offers members the knowledge, tools, and support needed to improve care quality and safety. Since 2018, our 290-plus members have expanded their knowledge, discussed problems faced by nationwide colleagues (and their solutions!), and collaborated with passionate peers. Highlights include:

  • QIPS Tips: SIG-developed resources teaching the basics of QI available in our member community
  • ASPHO webinar (January 2023) featuring Dr. Evan Orenstein discussing quality informatics and utilizing electronic health records to improve care (recording forthcoming)
  • “Works in Progress” sessions, writing groups, and community discussions for members to collaborate and receive expert advice on their own QIPS work
  • QI abstract-writing “clinic” featuring tips on writing a QI abstract and real-time editing for abstract drafts. We look forward to seeing those abstracts in Fort Worth, Texas, at #ASPHO2023!

To support the mission and impact of our rapidly growing SIG, we created working groups to manage ongoing initiatives. Please contact our leadership team to join a working group, become more involved in the SIG, or submit questions or ideas.

Learn more about ASPHO’s member communities and join a new SIG to expand your specialized network and knowledge.

New Fellows PLUS Membership Opportunity

Trainees in their 1st, 2nd, and 3rd year can their knowledge as a Fellow Membership PLUS member and receive 100 self-assessment questions featuring questions and rationales on key aspects of pediatric hematology/oncology practice. An updated set of 100 questions was added December 1, 2022. Multiple fellows from the same institution can join ASPHO with the group application.

Medical students and residents can also become members and learn about the subspecialty to shape their career paths. Make sure you are experiencing the full benefits of membership! Access on-demand recordings and resources such as past ASPHO webinars and case quizzes. Post questions to your peers in the Member Community and engage in Special Interest Groups.

Welcome, New Members

Please join ASPHO to welcome our newest members! We encourage you to connect on the Clinical Forum to welcome them to the ASPHO member community and expand your peer network. Meet the members who joined since the last issue of eNews.

Welcometo
Name, Credentials
Name, Credentials....

Case Quiz

case quizA 5-Year-Old with Anemia and Thrombocytopenia

The patient is a 5-year-old Caucasian female who is previously healthy and presented to an outside facility after she had syncope at home. For the prior 2 days, she had bloody diarrhea and development of pallor and fatigue. The day prior to presentation, she had one episode of hematemesis and was having epistaxis from both nostrils. She also had decreased oral intake and decreased urine output. Prior to development of these symptoms, she had no medical problems. She eats a regular diet including fruits, vegetables, and meats and no excess of cow’s milk.

Her labs were remarkable for a Hgb of 6 g/dL and platelet count (PLT) of 4x103/mcL, WBC 13x103/mcL with a normal differential. Total bili was elevated at 4.4 mg/dL. Her BUN was elevated at 44 mg/dL, and creatinine was elevated at 0.8 mg/dL. DAT was negative. She had an active nosebleed in the ED and hematemesis of 600 mL. She was given a dose of ceftriaxone and transferred to the ICU. Her neurologic exam was within normal limits. There was no indication of seizure activity from the history.

In the ICU, she was given a pRBC transfusion and platelet transfusions, and follow-up CBC showed Hgb improved to 10 g/dL and PLT improved to 67x103/mcL. LDH was elevated at 4159 U/L. PT was mildly prolonged at 15.9 sec with INR 1.2 and aPTT 30.3 sec. A respiratory PCR panel was positive for RSV.

Based on the clinical presentation and the most likely pathologic process, what would you expect to see on the peripheral smear?

Take the quiz.

Sara McElroy, MD; Shabnam Arsiwala, MD
Division of Pediatric Hematology Oncology & BMT
Children’s Mercy Hospital
Kansas City, MO

Conference Central

Register Now for #ASPHO2023

Registration is now open for the 2023 ASPHO Conference in Fort Worth, TX, May 10–13, 2023 with early bird savings through April 12. ASPHO is pleased to provide the home for the PHO community to reconnect, network, and learn. See below for an invitation from Conference Planning Committee Chair Karen Effinger, MD MS, and information about the conference.

“The 2023 ASPHO Conference Planning Committee has designed another remarkable program covering a wide array of topics presented by experts in the field to ensure there will be something for everyone. It will be a fantastic opportunity to hear updates on important topics, learn about cutting-edge research, form new networks, and connect with colleagues. We are so excited to see you in Fort Worth in May!” —Karen E. Effinger, MD MS, Chair, Conference Planning Committee

Take advantage of engaging programming at the conference, including

  • Presidential Symposium “Access to Pediatric Hematology/Oncology Healthcare Leading to Improved Outcomes in Under Resourced Countries” where ASPHO President Doug Graham, MD, will lead a panel with Drs. Michael DeBaun, David Poplack, and Carlos Rodriguez-Galindo
  • Luminary Speakers Stella T. Chou, MD, and Justin N. Baker, MD FAAP FAAHPM
  • Clinical Conundrum sessions, Special Interest Group workshops, Speed Mentoring, and Early Career RoundTable
  • Annual 5K, Opening Exhibit Hall Reception, and more!
  • Plus, the #ASPHO2023 experience is enhanced with the ASPHO Engage platform providing on-demand education for 60 days following the conference.

View the Conference Schedule and make your plans to join us in Fort Worth! ASPHO is excited to welcome medical student and pediatric resident members to #ASPHO2023 and introduce them to the ASPHO community as they learn about the PHO career path.

Learn more about this vibrant city as you plan your 2023 ASPHO Conference experience and explore Fort Worth’s culinary scene, outdoor experiences, western-themed attractions, and many more cultural offerings!

The conference will take place in-person, and we look forward to providing you with the opportunity to reconnect with colleagues and friends in Fort Worth. A virtual option will also be available to attendees who are unvaccinated or unable to attend in person.

Learn More and Register Now!

Career Center

See What's New in the PHO Job Market

Find the latest openings and opportunities in pediatric hematology/oncology with the ASPHO Career Center.

Take advantage of ASPHO's Career Center resources to stay on top of job openings in the field. Skim the Resources section for resume writing, coaching, reference check, search strategy videos, and more. Create a personal account to save job postings and skim FAQs to learn how to best navigate the site! The Career Center is the go-to source where institutions post employment and targeted recruitment opportunities in the field.

Stay Informed of #ASPHOAdvocacy!

Have you seen the latest issue of Advocacy Brief? Learn about important legislative and regulatory issues impacting PHO; #ASPHOadvocacy efforts to support members, patients, and the profession; and how to contact your legislators to support PHO.

Ewing Sarcoma Study
  • Products
    • KARE Toolkit: Knowledge and Assessment Resources
    • Recordings
    • Webinars
    • ASPHOcast
    • 2020 Compensation Survey
  • Online Review Course
  • Pediatric Blood & Cancer
    • Access Journal
    • Online Access Instructions
  • ASPHO eNews
    • August 2015 Enews
    • June 2015 Enews
    • April 2015 Enews
    • February 2015 Enews
    • December 2014 Enews
    • October 2014 Enews
    • August 2014 Enews
    • June 2014 Enews
    • April 2014 Enews
    • February 2014 Enews
    • December 2013 Enews
    • October 2013 Enews
    • August 2013 Enews
    • June 2013 Enews
    • April 2013 Enews
    • February 2013 Enews
    • October 2014 Enews
    • October 2015 Enews
    • December 2015 Enews
    • February 2016 Enews
    • April 2016 Enews
    • June 2016 Enews
    • August 2016 Enews
    • October 2016 Enews
    • December 2016 Enews
    • February 2017 Enews
    • April 2017 Enews
    • June 2017 Enews
    • August 2017 Enews
    • October 2017 Enews
    • December 2017 Enews
    • February 2018 Enews
    • April 2018 Enews
    • June 2018 Enews
    • August 2018 eNews
    • October 2018 eNews
    • February 2019 eNews
    • Member Insights: eNews 2018 Highlights
    • April 2019 eNews
    • June 2019 eNews
    • August 2019 eNews
    • October 2019 eNews
    • December 2019 eNews
    • February 2020 eNews
    • April 2020 eNews
    • June 2020 eNews
    • August 2020 eNews
    • October 2020 eNews
    • December 2020 eNews
    • April 2021 eNews
    • June 2021 eNews
    • August 2021 eNews
    • December 2021 eNews
    • February 2022 eNews
    • April 2022 eNews
    • June 2022 eNews
    • August 2022 eNews
    • October 2022 eNews
    • December 2022 eNews
    • February 2023 eNews
  • Pediatric Blood & Cancer - Call for Applications for Deputy Editor
  • October 2015 Enews
  • Advocacy Sample
  • News Briefs
  • Health Policy & Advocacy
    • 2016 August Advocacy Brief
    • 2016 December Advocacy Brief
    • 2017 February Advocacy Brief
    • 2017 May Advocacy Brief
    • 2017 September Advocacy Brief
    • 2017 November Advocacy Brief
    • 2018 Advocacy Brief - March
    • Contact Your Members of Congress
    • 2018-Advocacy-Brief-June
    • 2018-Advocacy-Brief-September
    • Advocacy Brief December 2018
    • 2019 Advocacy Brief - March
    • March 2019 Advocacy Brief
    • June 2019 Advocacy Brief
    • September 2019 Advocacy Brief
    • March 2020 Advocacy Brief
    • June 2020 Advocacy Brief
    • September 2020 Advocacy Brief
    • December 2020 Advocacy Brief
    • June 2021 Advocacy Brief
    • September 2021 Advocacy Brief
    • March 2022 Advocacy Brief
    • June 2022 Advocacy Brief
    • September 2022 Advocacy Brief
  • 2017 Workforce Survey Report
  • Help Fund the STAT Act
  • Practice and Quality
    • Choosing Wisely®
    • Position Paper
    • Endorsements
    • ASPHO Endorsements member only
Ewing Sarcoma study Feb23 enews
Advertising, Exhibits, & Support | Career Center | Calendar | Contact Us
Terms of Use & Privacy Policy » © The American Society of Pediatric Hematology/Oncology